ATE333875T1 - Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten - Google Patents

Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten

Info

Publication number
ATE333875T1
ATE333875T1 AT01402270T AT01402270T ATE333875T1 AT E333875 T1 ATE333875 T1 AT E333875T1 AT 01402270 T AT01402270 T AT 01402270T AT 01402270 T AT01402270 T AT 01402270T AT E333875 T1 ATE333875 T1 AT E333875T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
extracts
preparations containing
soyai
soflavone
Prior art date
Application number
AT01402270T
Other languages
English (en)
Inventor
Pierre Fabre
Rene Belle
Bernard Fabre
Original Assignee
Boiron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boiron filed Critical Boiron
Application granted granted Critical
Publication of ATE333875T1 publication Critical patent/ATE333875T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01402270T 2000-09-11 2001-08-31 Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten ATE333875T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0011515A FR2813790B1 (fr) 2000-09-11 2000-09-11 Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques

Publications (1)

Publication Number Publication Date
ATE333875T1 true ATE333875T1 (de) 2006-08-15

Family

ID=8854136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01402270T ATE333875T1 (de) 2000-09-11 2001-08-31 Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten

Country Status (10)

Country Link
US (1) US20020114786A1 (de)
EP (1) EP1186295B1 (de)
AT (1) ATE333875T1 (de)
CA (1) CA2356466A1 (de)
CY (1) CY1106211T1 (de)
DE (1) DE60121686T2 (de)
DK (1) DK1186295T3 (de)
ES (1) ES2267695T3 (de)
FR (1) FR2813790B1 (de)
PT (1) PT1186295E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003293977A1 (en) * 2002-10-16 2004-05-04 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
AU2003298659A1 (en) * 2002-11-15 2004-06-15 Cargill, Incorporated Soluble isoflavone compositions
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
CN102905712B (zh) 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR102362968B1 (ko) * 2019-11-25 2022-02-17 주식회사 쎌바이오텍 유산균 및 프리바이오틱스를 포함하는 갱년기 증상의 예방, 완화 또는 치료용 조성물
WO2025181244A1 (en) 2024-02-28 2025-09-04 International N&H Denmark Aps Use of probiotic combinations for alleviating menopausal symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3489930B2 (ja) * 1996-03-08 2004-01-26 株式会社ヤクルト本社 がん予防食品
WO1998021946A1 (en) * 1996-11-18 1998-05-28 Internutria, Inc. Composition and treatment for persistent reproductive transition symptoms
FI107014B (fi) * 1997-07-25 2001-05-31 Oriola Oy Terveysravintovalmiste
CN1184895C (zh) * 1998-07-16 2005-01-19 阿龙·塔博尔 大豆组合物及其促进健康的应用

Also Published As

Publication number Publication date
PT1186295E (pt) 2006-11-30
DE60121686T2 (de) 2007-05-03
US20020114786A1 (en) 2002-08-22
DK1186295T3 (da) 2006-10-30
CA2356466A1 (fr) 2002-03-11
EP1186295A1 (de) 2002-03-13
ES2267695T3 (es) 2007-03-16
EP1186295B1 (de) 2006-07-26
CY1106211T1 (el) 2011-06-08
FR2813790B1 (fr) 2004-03-12
FR2813790A1 (fr) 2002-03-15
DE60121686D1 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
DE60115842D1 (de) Ventilanordnung
DE69839699D1 (de) Vaginales lactobacillus-medikament
FR2790645B1 (fr) Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
DE60215951D1 (de) Piperidinderivate als antibakterielle mittel
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
GB9822440D0 (en) Medicaments
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
GB0112836D0 (en) Medicaments
GB0101577D0 (en) Compounds
ZA200104931B (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body.
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
MY162068A (en) Formulation of human antibodies for treating tnf-(alpha) associated disorders
EP1642506A3 (de) verwendung von äurestabilen subtilisinproteasen in tierfutter
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
DE60225590D1 (de) C-kithemmer zur behandlung von bakteriellen infektionen
ATE333875T1 (de) Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten
EP1908839A3 (de) Virulenzgene, Proteine und ihre Anwendung
NO20013787L (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
ATE307575T1 (de) Zusammensetzung geeignet als nahrungsmittelzusatz und zur anwendung bei darmerkrankungen sowie bei veränderter darmflora
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1186295

Country of ref document: EP

REN Ceased due to non-payment of the annual fee